Cargando…

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL

Detalles Bibliográficos
Autores principales: Bahlis, Nizar J, Trudel, Suzanne, Quach, Hang, Popat, Rakesh, Lonial, Sagar, Orlowski, Robert Z, Kim, Kihyun, Mateos, Maria-Victoria, Pawlyn, Charlotte, Ramasamy, Karthik, Martinez-Lopez, Joaquín, Casas-Avilés, Ignacio, Spirli, Alessia, Gong, Jing, Amatangelo, Michael, Katz, Jessica, Maciag, Paulo, Peluso, Teresa, Richardson, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430921/
http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63
_version_ 1785091075568828416
author Bahlis, Nizar J
Trudel, Suzanne
Quach, Hang
Popat, Rakesh
Lonial, Sagar
Orlowski, Robert Z
Kim, Kihyun
Mateos, Maria-Victoria
Pawlyn, Charlotte
Ramasamy, Karthik
Martinez-Lopez, Joaquín
Casas-Avilés, Ignacio
Spirli, Alessia
Gong, Jing
Amatangelo, Michael
Katz, Jessica
Maciag, Paulo
Peluso, Teresa
Richardson, Paul
author_facet Bahlis, Nizar J
Trudel, Suzanne
Quach, Hang
Popat, Rakesh
Lonial, Sagar
Orlowski, Robert Z
Kim, Kihyun
Mateos, Maria-Victoria
Pawlyn, Charlotte
Ramasamy, Karthik
Martinez-Lopez, Joaquín
Casas-Avilés, Ignacio
Spirli, Alessia
Gong, Jing
Amatangelo, Michael
Katz, Jessica
Maciag, Paulo
Peluso, Teresa
Richardson, Paul
author_sort Bahlis, Nizar J
collection PubMed
description
format Online
Article
Text
id pubmed-10430921
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309212023-08-17 P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL Bahlis, Nizar J Trudel, Suzanne Quach, Hang Popat, Rakesh Lonial, Sagar Orlowski, Robert Z Kim, Kihyun Mateos, Maria-Victoria Pawlyn, Charlotte Ramasamy, Karthik Martinez-Lopez, Joaquín Casas-Avilés, Ignacio Spirli, Alessia Gong, Jing Amatangelo, Michael Katz, Jessica Maciag, Paulo Peluso, Teresa Richardson, Paul Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430921/ http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Bahlis, Nizar J
Trudel, Suzanne
Quach, Hang
Popat, Rakesh
Lonial, Sagar
Orlowski, Robert Z
Kim, Kihyun
Mateos, Maria-Victoria
Pawlyn, Charlotte
Ramasamy, Karthik
Martinez-Lopez, Joaquín
Casas-Avilés, Ignacio
Spirli, Alessia
Gong, Jing
Amatangelo, Michael
Katz, Jessica
Maciag, Paulo
Peluso, Teresa
Richardson, Paul
P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title_full P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title_fullStr P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title_full_unstemmed P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title_short P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE-EXPANSION PHASE OF THE CC-92480-MM-001 TRIAL
title_sort p868: mezigdomide (mezi) plus dexamethasone (dex) in patients (pts) with relapsed/refractory multiple myeloma (rrmm): results from the dose-expansion phase of the cc-92480-mm-001 trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430921/
http://dx.doi.org/10.1097/01.HS9.0000970376.71405.63
work_keys_str_mv AT bahlisnizarj p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT trudelsuzanne p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT quachhang p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT popatrakesh p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT lonialsagar p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT orlowskirobertz p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT kimkihyun p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT mateosmariavictoria p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT pawlyncharlotte p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT ramasamykarthik p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT martinezlopezjoaquin p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT casasavilesignacio p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT spirlialessia p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT gongjing p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT amatangelomichael p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT katzjessica p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT maciagpaulo p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT pelusoteresa p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial
AT richardsonpaul p868mezigdomidemeziplusdexamethasonedexinpatientsptswithrelapsedrefractorymultiplemyelomarrmmresultsfromthedoseexpansionphaseofthecc92480mm001trial